Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TALENT-MS: Lidocaine vs Oxycodone for MS Neuropathic Pain
NCT00414453Phase 4Terminated
- Sponsor
- University of Rochester
- Start
- Jan 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in neuropathic pain, sponsored by University of Rochester. Primary endpoint: Mean Daily Diary Pain Ratings During Final Week of Each Treatment Period at 15 weeks. Started Jan 2007; status: terminated.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00414453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414453.